StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3016% below fair value
$394.48+4.32 (+1.11%)

Close on Nov 20, 2026Market cap $85.23BP/E 16.8Yield –

Elevance Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Elevance Health's free cash flow for the twelve months ending Sep 30, 2026 was $6.51B, up 72.9% year over year. For fiscal 2025 it was $3.17B, down 30.3% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $9.67B in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.17B-30.3%
FY2024Dec 31, 2024$4.55B-32.7%
FY2023Dec 31, 2023$6.77B-6.7%
FY2022Dec 31, 2022$7.25B-0.4%
FY2021Dec 31, 2021$7.28B-24.7%
FY2020Dec 31, 2020$9.67B+94.0%
FY2019Dec 31, 2019$4.98B+90.3%
FY2018Dec 31, 2018$2.62B-22.8%
FY2017Dec 31, 2017$3.39B+26.4%
FY2016Dec 31, 2016$2.69B-24.8%
FY2015Dec 31, 2015$3.57B+34.6%
FY2014Dec 31, 2014$2.65B+10.3%
FY2013Dec 31, 2013$2.41B+9.4%
FY2012Dec 31, 2012$2.20B-23.0%
FY2011Dec 31, 2011$2.85B+195.8%
FY2010Dec 31, 2010$965.30M-63.7%
FY2009Dec 31, 2009$2.66B+21.5%
FY2008Dec 31, 2008$2.19B-45.6%
FY2007Dec 31, 2007$4.02B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.00B+29.0%
Q2 FY2026Jun 30, 2026$1.63B-9.0%
Q1 FY2026Mar 31, 2026$4.10B+399.0%
Q4 FY2025Dec 31, 2025-$209.00M-154.4%
Q3 FY2025Sep 30, 2025$775.00M-67.0%
Q2 FY2025Jun 30, 2025$1.79B+1341.1%
Q1 FY2025Mar 31, 2025$821.00M-51.7%
Q4 FY2024Dec 31, 2024$384.00M–
Q3 FY2024Sep 30, 2024$2.35B+2.2%
Q2 FY2024Jun 30, 2024$124.00M-92.3%
Q1 FY2024Mar 31, 2024$1.70B-72.5%
Q4 FY2023Dec 31, 2023-$3.30B–
Q3 FY2023Sep 30, 2023$2.29B-50.3%
Q2 FY2023Jun 30, 2023$1.60B-25.8%
Q1 FY2023Mar 31, 2023$6.17B+169.7%
Q4 FY2022Dec 31, 2022-$1.82B-236.3%
Q3 FY2022Sep 30, 2022$4.62B+105.7%
Q2 FY2022Jun 30, 2022$2.16B+54.3%
Q1 FY2022Mar 31, 2022$2.29B-0.6%
Q4 FY2021Dec 31, 2021$1.33B-62.3%
Q3 FY2021Sep 30, 2021$2.25B–
Q2 FY2021Jun 30, 2021$1.40B-73.5%
Q1 FY2021Mar 31, 2021$2.30B-0.4%
Q4 FY2020Dec 31, 2020$3.54B+262.2%
Q3 FY2020Sep 30, 2020-$1.46B-204.3%
Q2 FY2020Jun 30, 2020$5.28B+334.0%
Q1 FY2020Mar 31, 2020$2.31B+65.5%
Q4 FY2019Dec 31, 2019$976.00M+582.5%
Q3 FY2019Sep 30, 2019$1.40B+454.0%
Q2 FY2019Jun 30, 2019$1.22B+435.7%
Q1 FY2019Mar 31, 2019$1.40B-30.1%
Q4 FY2018Dec 31, 2018$143.00M–
Q3 FY2018Sep 30, 2018$252.00M-88.5%
Q2 FY2018Jun 30, 2018$227.00M+1.6%
Q1 FY2018Mar 31, 2018$2.00B-22.0%
Q4 FY2017Dec 31, 2017-$1.58B-1556.6%
Q3 FY2017Sep 30, 2017$2.19B–
Q2 FY2017Jun 30, 2017$223.50M–
Q1 FY2017Mar 31, 2017$2.56B–
Q4 FY2016Dec 31, 2016$108.20M–

More Elevance Health figures

See a number that looks wrong?